Patents by Inventor Joe G. Assouline

Joe G. Assouline has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition with nanoparticle-based drug delivery combined with non-invasive radiographic monitoring model
    Patent number: 12285498
    Abstract: A mesoporous silica nanoparticle (“MSN”); a bioactive agent loaded into the MSN and an enteric coating encapsulating the surface of the MSN for oral administration or combination with more than one other pharmaceutical composition each having distinct bioactive agents.
    Type: Grant
    Filed: August 21, 2024
    Date of Patent: April 29, 2025
    Assignee: NANOMEDTRIX, LLC
    Inventors: Joe G Assouline, Sean K. Sweeney
  • Pharmaceutical composition with nanoparticle-based drug delivery combined with non-invasive radiographic monitoring model
    Patent number: 12102693
    Abstract: A mesoporous silica nanoparticle (“MSN”); a bioactive agent loaded into the MSN; and an enteric coating encapsulating the surface of the MSN for oral administration or combination with more than one other pharmaceutical composition each having distinct bioactive agents.
    Type: Grant
    Filed: August 25, 2023
    Date of Patent: October 1, 2024
    Assignee: NANOMEDTRIX, LLC
    Inventors: Joe G. Assouline, Sean K. Sweeney
  • Porous nanocarriers for the monitoring and treatment of bladder cancer
    Patent number: 11969483
    Abstract: Mesoporous silica nanoparticles (MSNs) that may be useful as ultrasound contrast agents for detecting and treating bladder cancer are described herein. The MSNs include a lanthanide, a fluorophore, and an agent detectable by ultrasound.
    Type: Grant
    Filed: October 13, 2020
    Date of Patent: April 30, 2024
    Assignee: NANOMEDTRIX, LLC
    Inventors: Joe G. Assouline, Sean K. Sweeney
  • POROUS NANOCARRIERS FOR THE MONITORING AND TREATMENT OF BLADDER CANCER
    Publication number: 20210113716
    Abstract: Mesoporous silica nanoparticles (MSNs) that may be useful as ultrasound contrast agents for detecting and treating bladder cancer are described herein. The MSNs include a lanthanide, a fluorophore, and an agent detectable by ultrasound.
    Type: Application
    Filed: October 13, 2020
    Publication date: April 22, 2021
    Inventors: Joe G. Assouline, Sean K. Sweeney